Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1411-1420 of 1755 for cancer

Edit search filters
  1. Mayo Clinic Vestibular Schwannoma Quality of Life Index Assessment

    Rochester, MN

  2. Ultrasensitive Detection Of Target Micro-RNAs And Nucleic Acids In Small Volume Blood Samples Of Advanced Stage Prostate And Kidney Cancer Patients

    Jacksonville, FL, Rochester, MN

  3. A Study To Compare Positron Emission Mammography With Contrast-Enhanced Breast MRI For Detecting Breast Cancer

    Rochester, MN

  4. Circulating Tumor DNA In Endometrial Cancer

    Rochester, MN

  5. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids

    Rochester, MN

  6. Quality-Adjusted Survival in Allogeneic Hematopoietic Cell Transplant Patients

    Rochester, MN

  7. A Study of the Quality of Life of Patients who have Hereditary Nonpolyposis Colorectal Cancer

    Rochester, MN

  8. Cytotoxic Activity of Lenalidomide in Combination with the Bispecific CD30/CD16a Therapeutic Monoclonal Antibody, AFM13

    Jacksonville, FL

  9. A Study to Compare Outcomes of Patients Who Underwent Open and Robotic Prostatectomy for Prostate Cancer

    Rochester, MN

  10. A Study to Identify Genetic Markers in Non-Cancerous Prostate Tissues, and Compare to Better Identify the Markers Unique to Prostate Cancer

    Rochester, MN

.

Mayo Clinic Footer